Open in interactive viewer → charts, metric popovers & call review

Chewy's Beat Arrived With a Receipt

The pet retailer cleared guidance on borrowed timing and tariff refunds — while quietly moving AI from slideware into the P&L.
CHWY · Earnings Call · 2026-09-09

A Beat Built on Timing, Not on a Turn

Chewy's fiscal Q2 headline was tidy: total revenue of $3.33B, up 7.3% year over year, at the high end of guidance; adjusted EBITDA margin of 6.8% against a 6.3%–6.4% guide. But the CFO told you exactly where the upside came from, and it wasn't the pet aisle:

approximately $10 million of the upside reflected timing related benefits, primarily tariff refunds that were received earlier than anticipated, as well as certain rebate benefits that shifted from the second half into the second quarter. The quarter also included more than $5 million of discrete benefits related to gift card breakage, inventory adjustments, and certain vendor funded merchandising activity.

Christopher S. Deppe, Chief Financial Officer · 2026-09-09
And then the punchline: "Taken together, these timing related and discrete items accounted for essentially all of the adjusted EBITDA outperformance relative to expectations." A beat that is a pull-forward is not a beat you underwrite — and to management's credit, they said so, raising only the low end of the full-year margin guide to 6.7%–6.8% while flagging the items as non-recurring. The demand backdrop is the same story investors have heard for a year. Sumit Singh framed it plainly: “we did not see a meaningful recovery in the more pressured consumer backdrop for the pet market. Importantly, however, we did not see further deterioration.” — Sumit Singh, Chief Executive Officer · 2026-09-09 The pet market is stable, not healing — and the broader pet category growth is still low single digit. Chewy's growth is therefore gain share plus mix, not category lift. Even sales growth guidance was narrowed rather than lifted; the downside scenario was explicitly deemed "less likely," not gone.

AI Graduates From Slideware to the P&L

Here is what is genuinely new. For several quarters, AI was a promise attached to a savings number. This quarter it acquired a customer. Chewy launched Kai, an AI assistant in the mobile app, and Kali, a voice agent in the vet clinics — the first tangible use cases of a strategy that had been architecture and intent. Singh: “We continue to expect AI related initiatives to generate low-tens of millions of dollars of cost savings in fiscal 2026, scaling to approximately $50 million on an annualized basis in fiscal 2027.” — Sumit Singh, Chief Executive Officer · 2026-09-09 On the surface that reads like a repeat of a number first aired in March — and it is. Ask how much of that is a durable profit stream, though, and management gets refreshingly honest: “As investors look to 2027, it would not be appropriate to mechanically layer the growing contribution... on top of our fiscal 26 margin trajectory.” — Sumit Singh, Chief Executive Officer · 2026-09-09 AI is framed as an offset to wage inflation and a reed inside the variable cost line, not a standalone pool of savings — which is the honest way to pitch a productivity program. The AI initiatives theme now appears across the tape too: agentic and use cases-style language is saturating software earnings this quarter (SailPoint's Agentic Suites, PEGA's Agentic Acceleration, Braze's AI adoption), so Chewy is riding a broad wave rather than inventing one.

Riding the Tariff-Refund Wave

Chewy's ~$10M tariff-refund timing benefit looks idiosyncratic until you look at the market-wide theme board, where Net tariff refunds is a top-ranked keyword for the quarter. American Eagle, Academy Sports, J.Jill and Signet all name-checked tariff refunds in their own recent reports. Chewy is not special here; it is one more retailer booking a one-time cash benefit into a commodity quarter. That is precisely why the market treats it as non-recurring — and why the stock's reaction matters more than the print.

A Cheap Stock That Keeps Getting Cheaper

The tape is voting: Chewy's shares are down roughly 19% over the last 90 trading days, sitting about 20% below their late-April peak, and more than 80% below the 2021 high. A fresh report on a name already in a drawdown is a different animal — the market has pre-discounted disappointment, so the bar was low and the borrowed beat was enough to clear it. The valuation reflects that: Price to Revenue of 0.4x and Price to Net Income of 17.9x are not the multiples of a story stock. Yet the fundamental engine is genuinely improving. Gross profit grew 9% yoy, faster than revenue, and operating income jumped 69% — the mix shift into health, pharmacy and sponsored ads is real, not narrative. The catch is cash: free cash flow (less SBC) collapsed to just $4M, down 98% sequentially, though management reiterated roughly 80% full-year conversion and a $612M cash-plus-securities balance with over $1B of total liquidity.

What to Watch

The real forward catalyst is not the pet category — it is Chewy Plus. On the call, Singh teased a redesign of the membership program: “meet the new Chewy Plus... cheaper, better, more care, integrated.” — Sumit Singh, Chief Executive Officer · 2026-09-09 The contrast with the prior quarter is striking. In March, Chewy Plus was still “in a test-and-learn phase” — Sumit Singh, Chief Executive Officer · 2026-03-25, with management declining to give penetration targets. Now it is being relaunched as an integrated health-and-loyalty product, and management flagged incremental attractive growth opportunities and net-new product launches in the back half. And there are two other things to bank on. Chewy added $200M of buybacks and pulled the weighted diluted share count down ~2% sequentially, a real per-share tailwind against a cheap multiple. Modern Animal and SmartPak both outperformed their underwriting, and the Modern Animal net-adds are not yet in guidance — a hidden kicker. Finally, the treat categories are the pressure point, with discretionary attachment softening: treats, toppers and premium SKUs are where the consumer is pulling back, while core food, meds and Autoship hold. That is a quality-of-revenue question worth tracking into Q3, when the timing benefits vanish and the underlying margin prints on its own.